Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study.
El Badri S, Tahir B, Balachandran K, Bezecny P, Britton F, Davies M, Desouza K, Dixon S, Hills D, Moe M, Pigott T, Proctor A, Shah Y, Simcock R, Stansfeld A, Synowiec A, Theodoulou M, Verrill M, Wadhawan A, Harper-Wynne C, Wilson C.
El Badri S, et al. Among authors: theodoulou m.
Breast. 2021 Dec;60:199-205. doi: 10.1016/j.breast.2021.10.010. Epub 2021 Oct 28.
Breast. 2021.
PMID: 34736090
Free PMC article.